0000000000586318

AUTHOR

Marie-pierre Vullierme

showing 3 related works from this author

CT and MR Imaging Evaluation of Hepatic Adenoma

2006

Hepatic adenoma is a rare benign epithelial tumor that is usually encountered in young women who use oral contraceptives. It is clinically significant because of the risk of hemorrhage and of its low-grade malignancy potential. Adenomas usually are mildly hypervascular at contrast-enhanced CT and MR imaging, and heterogeneous due to the presence of hemorrhage, necrosis, calcifications and fat. The objective of our study was to illustrate the CT and MR imaging findings of hepatic adenoma.

AdenomaAdultmedicine.medical_specialtyNecrosisAdenomaComputed tomographyMalignancyDiagnosis DifferentialRare DiseasesmedicineHumansRadiology Nuclear Medicine and imagingBenign epithelial tumormedicine.diagnostic_testbusiness.industryLiver NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingMr imagingstomatognathic diseasesLiverFocal Nodular HyperplasiaFemaleRadiologymedicine.symptomTomography X-Ray ComputedbusinessLiver pathologyJournal of Computer Assisted Tomography
researchProduct

Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment

2023

Purpose To investigate whether liver enhancing tumor burden (LETB) assessed at contrast-enhanced CT indicates early response and helps predict survival outcomes in patients with multifocal neuroendocrine liver metastases (NELM) after intra-arterial treatment. Materials and Methods This retrospective study included patients with NELM who underwent intra-arterial treatment with transarterial embolization (TAE) or chemoembolization (TACE) between April 2006 and December 2018. Tumor response in treated NELM was evaluated by using the Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST (mRECIST). LETB was measured as attenuation 2 SDs greater than that of a region of intere…

OncologyMale; Humans; Middle Aged; Tumor Burden; Retrospective Studies; Treatment Outcome; Chemoembolization Therapeutic/methods; Liver Neoplasms/diagnostic imaging; Liver Neoplasms/therapy; Tomography X-Ray Computed; Abdomen/GI; CT; Chemoembolization; Embolization; LiverRadiology Nuclear Medicine and imagingAbdomen/GI CT Chemoembolization Embolization LiverOriginal Research
researchProduct

Fibropolycystic Liver Disease: CT and MR Imaging Findings

2005

Fibropolycystic liver disease encompasses a spectrum of related lesions of the liver and biliary tract that are caused by abnormal embryologic development of the ductal plates. These lesions (congenital hepatic fibrosis, biliary hamartomas, autosomal dominant polycystic disease, Caroli disease, choledochal cysts) can be clinically silent or can cause signs and symptoms such as cholangitis, portal hypertension, gastrointestinal bleeding, infections, and space-occupying masses. The different types of fibropolycystic liver disease demonstrate characteristic findings at computed tomography (CT) and magnetic resonance (MR) imaging. Patients with congenital hepatic fibrosis typically have imaging…

Pathologymedicine.medical_specialtyCaroli diseaseBile Duct DiseasesLiver diseasemedicineHumansRadiology Nuclear Medicine and imagingCholedochal cystsmedicine.diagnostic_testCystsBile ductbusiness.industryLiver DiseasesMagnetic resonance imagingmedicine.diseaseFibrosisMagnetic Resonance ImagingCaroli Diseasemedicine.anatomical_structureLiverBiliary tractCongenital hepatic fibrosisPortal hypertensionBile DuctsRadiologyTomography X-Ray ComputedbusinessCholangiographyRadioGraphics
researchProduct